Dianaty Ali 4

What Happened

• Dianaty Ali, EVP & Chief Product & Technology Officer of MiniMed Group, received a total of 191,258 restricted stock units (RSUs) on March 11, 2026. These awards were granted as part of the conversion of previously held Medtronic restricted stock units and performance share units into MMED RSUs under the Employee Matters Agreement following MMED’s separation from Medtronic.
• No per-share prices or cash values are reported (N/A). The awards were granted under MMED’s 2026 Long Term Incentive Plan and will vest on various future dates (see Key Details). This is an award/conversion (code A) — not an open-market purchase or sale.

Key Details

• Transaction date: March 11, 2026; Form 4 filed March 13, 2026 (appears timely).
• Total RSUs received: 191,258; price/value: N/A (conversion based on formulas tied to Medtronic and MMED average prices per the Employee Matters Agreement).
• Vesting schedule (varies by tranche): includes vesting on Dec 6, 2026; installments on Oct 28, 2026 / Oct 28, 2027 / Oct 29, 2028; Apr 30, 2027; Apr 28, 2028; Jul 31, 2026; Jul 29, 2027; and Jul 28, 2028.
• Awards resulted from the Equity Award Conversion following MMED’s March 9, 2026 separation from Medtronic (per Form 8-K and the EMA).
• Shares owned after the transaction are not specified in the Form 4. No 10b5-1 plan, tax-withholding sale, or late filing is indicated in the filing.

Context

• These are time-vesting RSUs converted from Medtronic awards due to a corporate separation, not discretionary open-market trades. RSUs vest over time and do not represent immediate sales or purchases; they are commonly used to preserve employee equity value through corporate transactions.